ARTICLE | Company News
Biogen Idec, MAKScientific deal
March 19, 2012 7:00 AM UTC
MAKScientific granted Biogen Idec an option to license exclusive, worldwide rights to develop and commercialize discovery-stage products for multiple sclerosis (MS) and neurodegenerative diseases. Upo...